PRNewsWire - Health

BioCity's ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria
CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China's NMPA
Gold Coast Health Plan Announces Inaugural Grant Awards to Expand Health Care Access Across Ventura County
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter